Value of distant radiotherapy for patients with multiple myeloma and plasmacytoma in the era of modern pharmacologic therapy
Il'in, N.V.; Leenman, E.E.; Vinogradova, I.N.; Gracheva, A.V.; Tokaeva, A.V.
Voprosy Onkologii 58(6): 821-825
2012
ISSN/ISBN: 0507-3758 PMID: 23600311 Document Number: 659239
Document emailed within 1 workday
Related Documents
Ishiyama, T.; Watanabe, K.; Fukuchi, K.; Yajima, K.; Koike, M.; Tomoyasu, S.; Tsuruoka, N. 1994: The increase of CD5LOW+NK cells in patients with multiple myeloma and plasmacytoma Anticancer Research 14(2b): 725-730Kanaev, S.V. 2006: Modern technologies in distant radiotherapy of malignancies Voprosy Onkologii 52(5): 582-589
Biswas, G.; Bhagwat, R.; Khurana, R.; Prasad, N.; Sastry, P.S.R.K.; Parikh, P.M. 2005: Multiple myeloma presenting as a suprasellar plasmacytoma Journal of the Association of Physicians of India 53: 24
Kalyani, A.; Rohaizak, M.; Cheong, S.K.; Nor Aini, U.; Balasundaram, V.; Norlia, A. 2010: Recurrent multiple myeloma presenting as a breast plasmacytoma Medical Journal of Malaysia 65(3): 227-228
Matsuda, Y.; Kato, R.; Miyao, N.; Sato, S.; Konishi, Y.; Kon, S. 2010: A case of extramedullary plasmacytoma of testis converted to multiple myeloma Hinyokika Kiyo. Acta Urologica Japonica 56(10): 593-595
Voorhees, P.M.; Usmani, S.Z. 2016: The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy Clinical Advances in Hematology and Oncology: H&o 14(9): 719-728
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Kyle, R.A. 1999: Maintenance therapy and supportive care for patients with multiple myeloma Seminars in Oncology 26(5 Suppl 13: 35-42
Invernizzi, R.; Bergamaschi, G.; Cazzola, M. 1996: Acute promyelocytic leukemia complicating chemo-radiotherapy for multiple myeloma Haematologica 81(5): 483
Zharinov, G.M.; Zimin, A.A.; Samoĭlova, K.A.; Neklasova, N.I. 2011: Survival among patients with prostate cancer after distant radiotherapy and low-intensity near-infrared phototherapy Voprosy Onkologii 57(4): 457-461
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Avvisati, G.; Pulsoni, A.; Petrucci, M.T.; Tribalto, M. 1990: Therapy of multiple myeloma and its complications Recenti Progressi in Medicina 81(10): 642-650
Izumi, T. 2014: Novel targeted therapy in multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 72(6): 1089-1093
Gisslinger, H. 1997: Interferon alpha in the therapy of multiple myeloma Leukemia 11(Suppl 5): S52-S56
Rapazzini, P.; Bettini, R.; Masini, M.; Steidl, L.; Ferrari, V.; Piantanida, S. 1986: Therapy of multiple myeloma and monitoring of the response Recenti Progressi in Medicina 77(2): 95-99
Peest, D. 1998: Prognostic factors and standard therapy of multiple myeloma Praxis 87(25-26): 874-878
Fiorini, F.; Napoli, S.; Giordano, L.; Castelluccio, A. 1995: Renal involvement in multiple myeloma. Physiopathology and therapy Minerva Urologica e Nefrologica 47(3): 125-131
Górski, J.; Kicińska, M. 1990: Combined therapy of multiple myeloma: cytostatics and plasmapheresis Acta Haematologica Polonica 21(2): 166-172